1003-17: Clinical Treatment Targets in Addictions
This session will review approved medications and other medications or pharmacological targets under investigation for the treatment of alcohol use disorder.
Presenter: Lorenzo Leggio, MD, PhD, MSc
Disclosures: Dr. Leggio is a federal employee at the National Institutes of Health (NIH). In addition to the intramural NIH funding, he is the PI of a clinical study to be conducted in his NIH laboratory; this study has received partial funding from the Peter G. Dodge Foundation (PGDF). Dr. Leggio serves as an Editor-in-Chief for 'Alcohol and Alcoholism' (Oxford Press and MCA). Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur in this presentation.
Session Length: 1 hour 25 minutes
Target Audience: RN, APRN
Upon completion of this presentation, the participant will be able to:
- Identify FDA Approved medications.
- Identify non-FDA approved medications with off label use.
- Identify novel potential pharmacological targets under investigation.
Keywords: Addictions, Practice, Pharmacology
Continuing Nursing Education
1.5 pharmacology contact hours. * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
APNA 15th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Friday, June 9, 2017
9:45am - 11:15am
The contact hours for this session expire: June 30, 2019